https://www.indianpharmapost.com/zydus-receives-usfda-approval-usfda-to-initiate-phase-ii-clinical-trial-of-zyil1-for-parkinsons-disease-150242023-12-18T00:00:00+05:30always0.9https://www.indianpharmapost.com/lupin-receives-tentative-usfda-approval-for-sitagliptin-tablets-150252023-12-18T00:00:00+05:30always0.9https://www.indianpharmapost.com/zydus-receives-final-approval-from-the-usfda-for-lacosamide-tablets-150262023-12-18T00:00:00+05:30always0.9https://www.indianpharmapost.com/ami-organics-inks-agreement-with-fermion-for-two-additional-apis-150272023-12-18T00:00:00+05:30always0.9https://www.indianpharmapost.com/biocon-biologics-concludes-integration-of-acquired-biosimilars-business-in-120-countries-150282023-12-18T00:00:00+05:30always0.9